🔎 Trials Near Me

ホーム › 高血圧 › ミシガン州

ミシガン州における高血圧の臨床試験

ミシガン州内の拠点で、高血圧に関する18件の研究が参加者を募集しています。

ミシガン州内の都市

公式研究テキスト(英語)

AM vs PM Exercise Training

  • Michigan State University, East Lansing
被験者募集中
55歳〜80歳 · 女性 · 2026/10/01更新 · NCT06042439

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Revival Research Institute, LLC, Dearborn
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Revival Research Institute, LLC - Dearborn, Dearborn
  • Aa Mrc Llc, Flint
  • Elite Research Center, LLC, Flint
  • 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • Henry Ford Hospital, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Great Lakes Research Group, Inc., Bay City
  • Great Lakes Research Institute, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Ann Arbor
  • Research Site, Detroit
  • Research Site, Garden City
  • 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Henry Ford Hospital, Detroit
  • Henry Ford Providence Hospital, Southfield
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Flint
  • Clinical Trial Site, Lansing
  • Clinical Trial Site, Midland
  • 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109

Global Paradise System US Post Approval Study

  • Henry Ford Health, Detroit
  • Henry Ford St. John Hospital, Detroit
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • University of Michigan Health-West, Wyoming
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • Oakland Medical Research Center, Troy
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120

The RADIANCE CED Study

  • Henry Ford Hospital, Detroit
  • Henry Ford St. John Hospital, Detroit
被験者募集中観察研究
65歳以上 · 全性別 · 2026/07/16更新 · NCT07231757

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

  • Hurley Medical Center, Flint
被験者募集中
18歳〜99歳 · 全性別 · 2026/07/13更新 · NCT06391073

SPYRAL GEMINI Pilot Study

  • Henry Ford Providence Hospital, Southfield
被験者募集中
18歳〜80歳 · 全性別 · 2026/06/24更新 · NCT06907147

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)

  • University of Michigan, Ann Arbor
被験者募集中早期第1相健康なボランティア歓迎
18歳以上 · 全性別 · 2025/12/05更新 · NCT04532489

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

  • University of Michigan, Ann Arbor
被験者募集中早期第1相健康なボランティア歓迎
18歳以上 · 全性別 · 2025/12/05更新 · NCT04546126

Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)

  • Wayne Health Mobile Units, Detroit
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2025/07/15更新 · NCT06593496

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。